Clinical trial
The Purpose of This Clinical Study is to Prove That the Test Drug (AJU-S56 5%) is Superior to the Control Drug After 24 Weeks of Administration to Patients Who Have Moderate or Severe Dry Eye Syndrome
NCT06291194 is registered in ClinicalTrials.gov with AJU Pharm Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Purpose of This Clinical Study is to Prove That the Test Drug (AJU-S56 5%) is Superior to the Control Drug After 24 Weeks of Administration to Patients Who Have Moderate or Severe Dry Eye Syndrome
- Lead sponsor
- AJU Pharm Co., Ltd.
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- November 10, 2023
- Completion date
- May 31, 2024
- Enrollment
- 396 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.